Cogent Biosciences (COGT) Total Liabilities: 2017-2021
Historic Total Liabilities for Cogent Biosciences (COGT) over the last 4 years, with Sep 2021 value amounting to $18.1 million.
- Cogent Biosciences' Total Liabilities fell 23.79% to $18.1 million in Q3 2021 from the same period last year, while for Sep 2021 it was $18.1 million, marking a year-over-year decrease of 23.79%. This contributed to the annual value of $16.2 million for FY2020, which is 8.00% down from last year.
- Latest data reveals that Cogent Biosciences reported Total Liabilities of $18.1 million as of Q3 2021, which was up 15.50% from $15.7 million recorded in Q2 2021.
- In the past 5 years, Cogent Biosciences' Total Liabilities ranged from a high of $32.0 million in Q1 2019 and a low of $10.8 million during Q1 2021.
- Over the past 3 years, Cogent Biosciences' median Total Liabilities value was $17.7 million (recorded in 2019), while the average stood at $19.8 million.
- In the last 5 years, Cogent Biosciences' Total Liabilities slumped by 60.02% in 2020 and then spiked by 32.99% in 2021.
- Quarterly analysis of 5 years shows Cogent Biosciences' Total Liabilities stood at $20.8 million in 2017, then grew by 23.46% to $25.7 million in 2018, then tumbled by 31.26% to $17.7 million in 2019, then declined by 8.00% to $16.2 million in 2020, then declined by 23.79% to $18.1 million in 2021.
- Its last three reported values are $18.1 million in Q3 2021, $15.7 million for Q2 2021, and $10.8 million during Q1 2021.